Medline (MDLN) Stock Price
Medline Price
Over the last 3 years Medline grew revenue by 9.9% annually, reaching 28.43 B USD. Earnings per share have grown at 119.1% per year over the last 2 years. For Medline, the net margin of 4.1% is up versus -0.1% a few years ago. The consensus 12-month price target for Medline is 45.00 USD, about 26.9% above where the stock trades today. Of 34 analysts, 27 rate the stock a buy — an overall Buy consensus.
Medline stock price
Medline business model & stock analysis
Frequently asked questions about Medline
Analysts currently set an average price target of 46.33 USD for the Medline stock (median: 45.00 USD), implying +30.7 % versus the latest price. The consensus is based on 34 analyst ratings.
34 analysts currently rate the Medline stock: 27 recommend buying, 7 holding and 0 selling. For 2026, analysts expect Medline to generate revenue of 31.23 B USD and earnings per share of 2.41 USD.
Converted at the current exchange rate, the Medline share trades at 31.63 EUR (35.45 USD).
The expected revenue of Medline is 31.23 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Medline is 1.96 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Medline is currently 14.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medline stock.
The price-to-sales ratio (P/S) of Medline is currently 0.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Medline stock.
The Eulerpool Quality Score for Medline is 4/10.
The ISIN of Medline is US58507V1070. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Medline is MDLN. The ticker symbol is used to trade Medline shares on the stock exchange.
Medline stock
Medline Peer Group
All fundamentals and in-depth analysis of Medline
Our stock analysis for Medline stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medline. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.